Notice of Frequently Asked Questions for PAR-17-294 "Catalyzing Innovation in Late Phase Clinical Trial Design and Statistical Analysis Plans Resource Access (X01)"

Notice Number: NOT-HL-17-525

Key Dates
Release Date: July 6, 2017  

Related Announcements
PAR-17-294

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform potential applicants that the NHLBI has posted a set of Frequently Asked Questions (FAQs) regarding applications for PAR-17-294 "Catalyzing Innovation in Late Phase Clinical Trial Design and Statistical Analysis Plans (X01)”.

The FAQs are available at this site:
https://www.nhlbi.nih.gov/research/funding/catalyzing-innovation-late-phase-clinical-trial-design-and-statistical-analysis-plans-u34x01-foas

All applicants are encouraged to view the FAQs prior to submitting their application.

Inquiries

Please direct all inquiries to:

Andrei Kindzelski, MD, PhD
Division of Blood Diseases and Resources
National Heart, Lung and Blood Institute (NHLBI)
Telephone: 301-435-0050
Email: kindzelskial@nhlbi.nih.gov
 
Kristin Burns, MD
Division of Cardiovascular Sciences
National Heart, Lung and Blood Institute (NHLBI)
Telephone: 301-594-6859
Email: kristin.burns@nih.gov

Lora Reineck, MD, MS
Division of Lung Diseases
National Heart, Lung and Blood Institute (NHLBI)
Telephone: 301-435-0222
Email: lora.reineck@nih.gov

Cheryl Boyce, PhD
Center for Translation Research and Implementation Science
National Heart, Lung and Blood Institute (NHLBI)
Telephone: 301-496-1051
Email: cheryl.boyce@nih.gov